01 5Increlex
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2015 Revenue in Millions : 14
2014 Revenue in Millions : 22
Growth (%) : 57%
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2016 Revenue in Millions : 25
2015 Revenue in Millions : 21
Growth (%) : 20
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2017 Revenue in Millions : 28
2016 Revenue in Millions : 29
Growth (%) : -3
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2018 Revenue in Millions : 27
2017 Revenue in Millions : 26
Growth (%) : 5%
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2014 Revenue in Millions : 1%
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?